FDA OKs Lyrfigtu for previously treated bile duct cancer
The FDA approved lirafugratinib — a kinase inhibitor — for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma.The indication for lirafug...
Search fresh public links, source activity, and ready-to-use post angles for Bile Duct Cancer.
Fresh curated links around bile duct cancer are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The FDA approved lirafugratinib — a kinase inhibitor — for adults with previously treated unresectable, locally advanced or metastatic cholangiocarcinoma.The indication for lirafug...
A new review in Cancer Reports proposes that the extracellular matrix protein COL6A1, overexpressed in the fibrotic stroma of cholangiocarcinoma, may drive tumor progression throug...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.